# VYDUO
> **ANDA210596** · Abbreviated New Drug Application (Generic) · Sponsor: PRINSTON INC · Approved 2022-09-19
## Drug
- **FDA Application Number:** ANDA210596
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** VYDUO
- **Generic name:** Nebivolol Hydrochloride
- **Active ingredients:** NEBIVOLOL HYDROCHLORIDE; VALSARTAN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** PRINSTON INC
- **First approval:** 2022-09-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210596)
---
*MORVS · CC0 1.0*